Literature DB >> 32420534

CT-guided percutaneous aspiration of Tarlov cyst: a case report of 2-year follow up.

Ertugrul Sahin1, Sang-Ho Lee2, Sang Soo Eun1.   

Abstract

Tarlov cysts are a rare pathology characterized by sac formations at the nerve root in the sacrum. Although many options have been proposed, there is still no consensus regarding the optimal treatment strategy. The authors report a case involving a 43-year woman with a sacral perineural cyst causing buttock pain and anus discomfort for 4 years. The patient successfully underwent computed tomography (CT)-guided aspiration. She currently has no symptoms, and 2-year follow-up magnetic resonance imaging revealed a decrease in cyst size. CT-guided aspiration is a safe and effective treatment option, and leads to improvement in cyst-related symptoms with minimal risk. 2020 AME Case Reports. All rights reserved.

Entities:  

Keywords:  CT guided aspiration; Tarlov cyst; case report; magnetic resonance imaging (MRI); perineural cyst

Year:  2020        PMID: 32420534      PMCID: PMC7221350          DOI: 10.21037/acr.2020.04.01

Source DB:  PubMed          Journal:  AME Case Rep        ISSN: 2523-1995


  4 in total

1.  CT-guided percutaneous aspiration of Tarlov cyst as a useful diagnostic procedure prior to operative intervention.

Authors:  J-Y Lee; P Impekoven; W Stenzel; M Löhr; R-I Ernestus; N Klug
Journal:  Acta Neurochir (Wien)       Date:  2004-05-21       Impact factor: 2.216

2.  Cysts (perineurial) of the sacral nerve roots: another cause of the sciatic or sacral cauda equina syndrome.

Authors:  I M TARLOV
Journal:  J Neuropathol Exp Neurol       Date:  1952-01       Impact factor: 3.685

3.  The clinical relevance of Tarlov cysts.

Authors:  Andrew John Langdown; Julian R B Grundy; Nicholas C Birch
Journal:  J Spinal Disord Tech       Date:  2005-02

4.  Microsurgical treatment of symptomatic sacral Tarlov cysts.

Authors:  P V Mummaneni; L H Pitts; B M McCormack; J M Corroo; P R Weinstein
Journal:  Neurosurgery       Date:  2000-07       Impact factor: 4.654

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.